Zobrazeno 1 - 10
of 4 235
pro vyhledávání: '"Knowles, MA"'
Autor:
Kpeglo D; Molecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, LS2 9 JT, UK. S.Peyman@leeds.ac.uk., Haddrick M; Medicines Discovery Catapult, Block 35, Mereside Alderley Park, Alderley Edge, SK10 4TG, UK., Knowles MA; Leeds Institute of Medical Research at St James's (LIMR), School of Medicine, University of Leeds, LS2 9 JT, UK., Evans SD; Molecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, LS2 9 JT, UK. S.Peyman@leeds.ac.uk., Peyman SA; Molecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, LS2 9 JT, UK. S.Peyman@leeds.ac.uk.; Leeds Institute of Medical Research at St James's (LIMR), School of Medicine, University of Leeds, LS2 9 JT, UK.
Publikováno v:
Lab on a chip [Lab Chip] 2024 Feb 13; Vol. 24 (4), pp. 854-868. Date of Electronic Publication: 2024 Feb 13.
Autor:
Martin HL; BioScreening Technology Group, Leeds Institutes of Molecular Medicine, University of Leeds, Leeds LS9 7TF, UK; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's University Hospital, University of Leeds, Leeds LS9 7TF, UK; School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK., Turner AL; School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK; Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK., Higgins J; BioScreening Technology Group, Leeds Institutes of Molecular Medicine, University of Leeds, Leeds LS9 7TF, UK., Tang AA; School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK; Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK., Tiede C; School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK; Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK., Taylor T; School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK., Siripanthong S; School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK; Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK., Adams TL; School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK; Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK., Manfield IW; School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK; Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK., Bell SM; BioScreening Technology Group, Leeds Institutes of Molecular Medicine, University of Leeds, Leeds LS9 7TF, UK; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's University Hospital, University of Leeds, Leeds LS9 7TF, UK., Morrison EE; BioScreening Technology Group, Leeds Institutes of Molecular Medicine, University of Leeds, Leeds LS9 7TF, UK; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's University Hospital, University of Leeds, Leeds LS9 7TF, UK., Bond J; BioScreening Technology Group, Leeds Institutes of Molecular Medicine, University of Leeds, Leeds LS9 7TF, UK; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's University Hospital, University of Leeds, Leeds LS9 7TF, UK., Trinh CH; School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK; Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK., Hurst CD; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's University Hospital, University of Leeds, Leeds LS9 7TF, UK., Knowles MA; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's University Hospital, University of Leeds, Leeds LS9 7TF, UK., Bayliss RW; School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK; Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK., Tomlinson DC; BioScreening Technology Group, Leeds Institutes of Molecular Medicine, University of Leeds, Leeds LS9 7TF, UK; School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK; Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK. Electronic address: d.c.tomlinson@leeds.ac.uk.
Publikováno v:
Cell reports [Cell Rep] 2023 Oct 31; Vol. 42 (10), pp. 113184. Date of Electronic Publication: 2023 Sep 29.
Autor:
Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Hansel DE; Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Efstathiou JA; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Knowles MA; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Leeds, UK., Galsky MD; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Teoh J; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China., Theodorescu D; Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA. dan.theodorescu@cshs.org.; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. dan.theodorescu@cshs.org.; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. dan.theodorescu@cshs.org.
Publikováno v:
Nature reviews. Disease primers [Nat Rev Dis Primers] 2023 Oct 26; Vol. 9 (1), pp. 58. Date of Electronic Publication: 2023 Oct 26.
Autor:
Hurst, CD, Cheng, G, Platt, FM, Alder, O, Black, EVI, Burns, JE, Brown, J, Jain, S, Roulson, J, Knowles, MA
Pure squamous cell carcinoma (SCC) is the most common pure variant form of bladder cancer, found in 2–5% of cases. It often presents late and is unresponsive to cisplatin-based chemotherapy. The molecular features of these tumours have not been elu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::7270052d33dbe3e2364569ce73aee7b4
Publikováno v:
Matrix Biology Plus. 14:100109
Despite improvements in the understanding of disease biology, pancreatic ductal adenocarcinoma (PDAC) remains the most malignant cancer of the pancreas. PDAC constitutes ∼95% of all pancreatic cancers, and it is highly resistant to therapeutics. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49d43d87e70e50b0e7d127d4d16cc924
https://doi.org/10.1016/j.mbplus.2022.100109
https://doi.org/10.1016/j.mbplus.2022.100109
Publikováno v:
The Expository Times; January 2001, Vol. 112 Issue: 4 p136-137, 2p
Autor:
Mostafid, AH, Porta, N, Cresswell, J, Griffiths, TRL, Kelly, JD, Penegar, SR, Davenport, K, McGrath, JS, Campain, N, Cooke, P, Masood, S, Knowles, MA, Feber, A, Knight, A, Catto, JWF, Lewis, R, Hall, E
Publikováno v:
Bju International
Objectives: To evaluate the activity of intravesical mitomycin‐C (MMC) to ablate recurrent low‐risk non‐muscle‐invasive bladder cancer (NMIBC) and assess whether it may enable patients to avoid surgical intervention for treatment of recurrenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a020a021eb2343fee66ecf1eb9cd6b56
https://pubmed.ncbi.nlm.nih.gov/32805758
https://pubmed.ncbi.nlm.nih.gov/32805758
Development of resistance to FGFR inhibition in urothelial carcinoma via multiple pathways in vitro.
Autor:
Pettitt GA; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Leeds, UK., Hurst CD; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Leeds, UK., Khan Z; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Leeds, UK., McPherson HR; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Leeds, UK., Dunning MC; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Leeds, UK., Alder O; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Leeds, UK., Platt FM; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Leeds, UK., Black EV; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Leeds, UK., Burns JE; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Leeds, UK., Knowles MA; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Leeds, UK.
Publikováno v:
The Journal of pathology [J Pathol] 2023 Feb; Vol. 259 (2), pp. 220-232. Date of Electronic Publication: 2022 Dec 13.
A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma.
Autor:
Warrick JI; Department of Pathology and Laboratory Medicine, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA, 17033, USA. jwarrick@pennstatehealth.psu.edu.; Department of Urology, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA. jwarrick@pennstatehealth.psu.edu., Knowles MA; Divison of Molecular Medicine, Leeds Institute of Molecular Research at St James's, St James's University Hospital, Beckett Street, Leeds, LS9 7TF, UK., Hurst CD; Divison of Molecular Medicine, Leeds Institute of Molecular Research at St James's, St James's University Hospital, Beckett Street, Leeds, LS9 7TF, UK., Shuman L; Department of Urology, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA., Raman JD; Department of Urology, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA., Walter V; Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.; Department of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA., Putt J; Department of Pathology and Laboratory Medicine, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA, 17033, USA., Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Groeneveld C; Cartes d'Identité des Tumeurs (CIT) Program, Ligue Nationale Contre le Cancer, Équipe Oncologie Moleculaire, Institut Curie, Paris, France., Castro MAA; Bioinformatics and Systems Biology Laboratory, Federal University of Paraná, Curitiba, PR, 81520-260, Brazil., Robertson AG; Bioinformatics, BC Cancer Agency, Vancouver, BC, Canada., DeGraff DJ; Department of Pathology and Laboratory Medicine, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA, 17033, USA. ddegraff@pennstatehealth.psu.edu.; Department of Urology, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA. ddegraff@pennstatehealth.psu.edu.; Department of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA. ddegraff@pennstatehealth.psu.edu.
Publikováno v:
Scientific reports [Sci Rep] 2022 Oct 03; Vol. 12 (1), pp. 16538. Date of Electronic Publication: 2022 Oct 03.
Autor:
Marzouka NA; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Eriksson P; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Bernardo C; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Hurst CD; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Leeds, United Kingdom., Knowles MA; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Leeds, United Kingdom., Sjödahl G; Urology-Urothelial Cancer, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden., Liedberg F; Urology-Urothelial Cancer, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden., Höglund M; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. Electronic address: mattias.hoglund@med.lu.se.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2022 Sep; Vol. 24 (9), pp. 992-1008. Date of Electronic Publication: 2022 Jul 16.